Neovasc Inc. (TSE:NVCN – Get Free Report) shares shot up 0.6% during trading on Monday . The company traded as high as C$40.15 and last traded at C$40.15. 399 shares were traded during mid-day trading, a decline of 81% from the average session volume of 2,123 shares. The stock had previously closed at C$39.92.
Neovasc Stock Performance
The company has a quick ratio of 8.04, a current ratio of 8.44 and a debt-to-equity ratio of 44.86. The company has a 50-day moving average of C$40.15. The company has a market capitalization of C$110.81 million, a PE ratio of -1.96 and a beta of 2.01.
Neovasc Company Profile
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
Read More
- Five stocks we like better than Neovasc
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Calculate Inflation Rate
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
